Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
about
Interventions for preventing oral candidiasis for patients with cancer receiving treatmentA systematic review of oral fungal infections in patients receiving cancer therapy.Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.Towards a targeted, risk-based, antifungal strategy in neutropenic patients.Evidence-based guidelines for empirical therapy of neutropenic fever in Korea.Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysManagement of fungal infections following allogeneic stem cell transplantation.Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.Antifungal prophylaxis during treatment for haematological malignancies: are we there yet?Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.Synthesis and antifungal activity of the novel triazole derivatives containing 1,2,3-triazole fragment.Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis.Improved efficacy of fluconazole against candidiasis using bio-based microemulsion technique
P2860
Q24243005-FD469593-F197-45DF-A234-C71E240E8162Q30431307-0976C038-C4C9-4DDE-9425-E764E3034C99Q30596268-DBFBFC7F-990A-435E-BBF8-63B7C866DE3BQ34022479-393528C7-D84C-45BF-AF02-6BB66DD44E29Q35033597-8B35B109-4681-42BE-B6B3-5EC370749E8BQ35833407-80D3BE5E-80D6-44EA-BB89-6C856EED8E3FQ35949528-5092D1BE-F8B7-4568-ACE5-E2DD0EBE0328Q37202860-6E011EA8-B766-4407-9977-01F9E451A5E8Q37344532-29BE2EA1-125B-4480-A35B-4F492A727196Q37621550-9468C907-90C5-4C5D-8CC1-754C9B2B7156Q37866827-E42017D6-250A-45EC-B9CC-10EB0E5347B6Q38178526-E2C3EE3A-B56E-4C24-9DE1-DD0EABD5CE59Q42711526-D18A6C52-D2D2-4AB3-846B-88349FA4575CQ51177786-082B9A1E-2B03-4D88-8E69-9282C5070483Q57173032-4E419C09-B90D-4618-B456-8D0D3B8424CA
P2860
Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@ast
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@en
type
label
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@ast
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@en
prefLabel
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@ast
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@en
P2093
P2860
P356
P1476
Fluconazole versus itraconazol ...... nfections in haemato-oncology.
@en
P2093
Huijgens PC
Jonkhoff AR
Ossenkoppele GJ
Simoons-Smit AM
van Loenen AC
van Tinteren H
P2860
P304
P356
10.1136/JCP.52.5.376
P407
P577
1999-05-01T00:00:00Z